The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

In the healthcare industry, early detection of diseases is crucial, especially for conditions like HIV. The 4th Generation ...

The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...

Market is set to witness a CAGR of 4.5% from 2021 to 2026. High adoption of point-of-care (POC) diagnostics, availability of advanced rapid testing devices, growing number of infectious & other ...

The HIV/HBV/HCV test kits market plays a vital role in the global fight against infectious diseases. These diagnostic tools are crucial for early detection and effective treatment of HIV, hepatitis B ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...